Lineage Cell Therapeutics, Inc. Financial Ratios — LCTX.TA

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-81.47	-116.09	-66.16	-98	40.54	-14.08	-36.13	-11.36	-19.34	-43.61	-30.14	-29.97	-25.19	-97.95
Return on Assets (%)	-33.33	-56.7	-100.33	-54.91	-55.43	28.3	-12.65	-33.46	-10.31	-17.69	-30.46	-17.62	-19.13	-17.37	-56.27
Return on Capital (%)	- -	- -	- -	- -	- -	40.79	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-54.59	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	95.24	74.35	72.28	57.01	56.31	84.1	90.62	78.67	72.12	50.19	63.4	95.05	92.5	96.48	99
EBITDA Margin (%)	-979.13	-1,309.45	-1,208.46	-2,171.08	-2,347.08	-2,407.19	-2,084.82	-2,663.98	-2,427.33	-3,157.57	-1,240.71	-148.22	-268.76	-219.7	-144.82
Operating Margin (%)	-1,120.98	-1,476.82	-1,346.63	-2,603.08	-2,597.04	-2,618.43	-2,268.75	-2,895.13	-2,630.31	-3,421.35	-1,263.12	-153.17	-276.5	-226.11	-149.62
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,106.43	-1,494.85	-1,964.03	-2,627.38	-2,472.38	826.87	-1,299.61	-3,328.39	-1,301.35	-2,836.22	-1,110.63	-175.56	-260.28	-195.62	-471.61
Profit Margin (%)	-990.74	-1,265.64	-1,533.83	-1,870.16	-1,854.42	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Net Income to Common Margin (%)	-990.74	-1,265.64	-1,533.83	-1,874.63	-1,870.8	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	0.17	0.6	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-81.47	-116.09	-66.05	-97.42	40.54	-14.08	-36.13	-11.36	-19.34	-43.61	-30.14	-29.97	-25.19	-97.95

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
ST Debt	- -	- -	- -	- -	- -	1	- -	- -	1	1	1	1	1	1	1
LT Debt	- -	- -	- -	- -	5	3	1	2	4	3	2	3	2	1	2
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.09	-0.07	-0.04	-0.06	-0.14	-0.16	-0.06	-0.18	-0.12	-0.12	-0.11
Net Debt/EBITDA	1.36	0.2	0.16	0.69	0.7	0.37	0.98	0.62	0.26	1.31	1.15	0.52	1.47	2.19	1.94
Total Debt/EBIT	- -	- -	- -	-0.01	-0.08	-0.07	-0.04	-0.06	-0.13	-0.14	-0.06	-0.17	-0.12	-0.12	-0.11
Net Debt/EBIT	1.19	0.17	0.14	0.58	0.63	0.34	0.9	0.57	0.24	1.21	1.13	0.5	1.43	2.13	1.87
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	75.66	60.26	99.91	70.31	46.57	85.26	93.62	90.9	90.57	92.51	55.82	62.19	65.82	71.77	43.05
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.57	4.98	2.06	0.71	2.1	3.37	2.48	1.99	3.71	3.04	1.65	3.15
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
Net Debt to Equity	-53.58	-17.91	-13	-46.82	-54.4	-15.33	-22.32	-25.49	-8.54	-33.7	-61.32	-15.78	-57.14	-59.46	-94.11
Net Debt/Capital (%)	-87.88	-15.38	-6.9	-54.93	-72.22	-17.24	-28.53	-33.84	-8.83	-45.78	-129.13	-16.69	-108.71	-125.06	-458.64
EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
EBITDA-CapEx	-17	-23	-37	-43	-65	-57	-39	-41	-36	-24	-49	-22	-25	-21	-22
Operating Income (Loss)	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.06	0.99	0.79	4.17	3.45	2.57	5.55	4.51	4.73	5.35	1.24	3.05	1.98	3.42	4.91
Current Ratio	7.93	1.64	1.14	4.58	3.79	2.9	6.2	5.34	8.86	5.66	2.37	3.16	2.14	3.65	5.2
Quick Ratio	7.06	0.99	0.95	4.37	3.58	2.7	5.99	5.06	8.42	5.35	2.32	3.06	2.02	3.47	4.99
CFO/Avg Current Liab	-4.83	-5.22	-5.2	-5.54	-4.56	-3.97	-3.88	-4.51	-4.8	-2.77	-0.86	0.03	-1.55	-1.45	-1.49
Common Equity/Total Assets	75.66	60.26	99.91	70.31	46.57	85.26	93.62	90.9	90.57	92.51	55.82	62.19	65.82	71.77	43.05
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.57	4.98	2.06	0.71	2.1	3.37	2.48	1.99	3.71	3.04	1.65	3.15
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
CFO/Total Liabilities	-310.97	-360.81	-190.78	-319.05	-244.57	-350.85	-339.91	-328.04	-224.49	-154.06	-28.17	2.05	-73.25	-63.78	-27.32
CFO/CapEx	-14.13	-49.1	-12.96	-55.35	-8.35	-16.76	-23.01	-9.4	-72.61	-308.64	-69.3	2.56	-42.38	-40.87	-36.24
Altman's Z-Score	-5.38	-23.77	-28.4	-10.82	3.24	14.82	14.84	3.4	-1.72	3.16	-1.79	-5.64	272.68	153.05	311.11

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	5.13	1.81	2.39	2.96	2.92	1.83	2.73	4.82	0.15	0.58	17.17	13.74	19.04
Days Sales Outstanding	- -	- -	71.14	202.2	152.68	123.5	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventory Turnover	1.64	8.16	6.78	3.76	8.29	716	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	222.14	44.75	53.85	96.96	44.02	0.51	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.15	0.38	0.4	0.32	0.33	0.16	0.13	0.18	0.17	0.15	0.46	0.25	0.3	0.21	0.08
Accounts Payable Turnover Days	2,397.8	951.68	916.67	1,131.71	1,104.32	2,244.7	2,749.45	1,992.39	2,120.01	2,388.14	787.59	1,488.08	1,208.42	1,761.62	4,393.75
Cash Conversion Cycle	-2,175.66	-906.93	-791.68	-832.54	-907.62	-2,120.69	-2,624.59	-1,793.01	-1,986.16	-2,312.36	1,594.09	-853.34	-1,187.16	-1,735.05	-4,374.58
Inventory to Cash Days	-222.14	-44.75	17.28	105.24	108.67	122.99	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	344	366	257	127	119	261	409	189	18,593	9,862	36,975
- Cash & Cash Equivalents	22	4	5	29	42	22	37	24	9	33	56	11	35	46	41
+ Preferred Equity and Hybrid Capital	- -	- -	- -	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	13	15	27	26	51	13	2	-2	-2	-1	-1	-1	-1	-1	-1
+ Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
Enterprise Value	-9	10	22	1	357	360	222	97	92	222	353	134	18,559	9,816	36,921
Total Capital	47	33	85	83	100	138	165	93	117	103	99	79	68	82	50
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt / EV	- -	- -	- -	0.66	0.01	0.01	0.01	0.02	0.06	0.02	0.01	0.03	- -	- -	- -
EV/Sales	- -	6.12	7.68	0.41	140.86	159.72	124.1	68.78	62.1	287.27	90.48	9.1	2,074.83	1,033.33	2,536.46
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	126.27	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	90.85	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	344	374	257	127	119	261	409	189	18,593	9,862	36,975
Diluted Enterprise Value	-9	10	22	1	358	369	224	105	113	231	355	180	18,559	9,818	36,936
EV per Share	- -	0.21	0.41	0.01	4.48	3.7	1.94	0.77	0.63	1.48	2.14	0.79	107.49	49.03	160.44
TTM Sales	2	2	3	2	3	2	2	1	1	1	4	15	9	9	15
TTM EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
TTM Operating Income	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22
TTM Cash Flow to Firm	-14	-20	-30	-39	-45	-42	-31	-31	-32	-20	-24	1	-29	-23	-19
TTM Free Cash Flow to Firm	-13	-19	-27	-38	-39	-40	-29	-28	-32	-20	-23	1	-28	-23	-18

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	-8.78	-9.4	-8.82	-4.62	-3.78	-13.25	-17.63	128.47	-666.62	-437.8	-2,009.85
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-9	10	22	1	357	360	222	97	92	222	353	134	18,559	9,816	36,921
Low Price	- -	- -	- -	- -	0.03	1.94	2.19	0.85	0.54	0.58	1.67	1.02	0.95	48.85	36.52
EV/Sales	- -	6.12	7.68	0.41	140.86	159.72	124.1	68.78	62.1	287.27	90.48	9.1	2,074.83	1,033.33	2,536.46
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	10.9	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	-5.94	8.62	-16.82	-6.22	-13.03	-7.63	-9.46	-9.17	-112.69	-1,035.18	-364.84
Price/Earnings High	- -	- -	- -	- -	-7.67	12.41	-21.49	-8.54	-21.23	-14.21	-16.35	-17.1	-956.72	-1,665.63	-740.13
Price/Earnings Low	- -	- -	- -	- -	-0.06	5.62	-12.55	-2.34	-6.71	-4.22	-6.4	-6.61	-7.67	-525.49	-132.29
Price/Book Value	- -	- -	- -	- -	7.81	3.01	1.59	1.38	1.05	2.61	4.2	2.46	279.65	121.37	762.86
Price/Book Value Average	- -	- -	- -	- -	6.39	2.38	2.07	3.1	1.34	1.58	4.18	3.13	36.42	237.07	478.24
Price/Book Value High	- -	- -	- -	- -	8.24	3.43	2.65	4.25	2.19	2.94	7.22	5.84	309.17	381.45	970.15
Price/Book Value Low	- -	- -	- -	- -	0.06	1.55	1.55	1.16	0.69	0.87	2.83	2.26	2.48	120.34	173.41
Price/Tangible Book Value	- -	- -	- -	- -	8.03	3.04	1.64	1.43	2.27	6.97	12.26	12.98	3,882.5	498.09	37,962.28
Price/Tangible Book Value Average	- -	- -	- -	- -	6.57	2.41	2.14	3.21	2.91	4.21	12.19	16.53	505.57	972.91	23,798.39
Price/Tangible Book Value High	- -	- -	- -	- -	8.48	3.46	2.73	4.41	4.75	7.84	21.06	30.84	4,292.36	1,565.44	48,277.61
Price/Tangible Book Value Low	- -	- -	- -	- -	0.06	1.57	1.59	1.21	1.5	2.33	8.24	11.93	34.43	493.88	8,629.33
Price/Sales	- -	- -	- -	- -	135.83	162.46	143.64	90.02	80.54	337.47	105.08	12.86	2,078.62	1,038.24	2,540.21
Price/Sales Average	- -	- -	- -	- -	111.18	128.49	187.55	202.05	103.2	203.85	104.48	16.38	270.68	2,027.97	1,592.45
Price/Sales High	- -	- -	- -	- -	143.41	185.08	239.53	277.38	168.16	379.64	180.56	30.56	2,298.05	3,263.05	3,230.45
Price/Sales Low	- -	- -	- -	- -	1.05	83.71	139.91	75.95	53.18	112.62	70.66	11.82	18.43	1,029.45	577.42
Price/Cash Flow	- -	- -	- -	- -	-7.73	-8.64	-8.43	-4.13	-3.73	-13.21	-17.38	178.57	-650.89	-427.09	-1,954.4
Price/Cash Flow Average	- -	- -	- -	- -	-6.33	-6.84	-11.01	-9.26	-4.77	-7.98	-17.28	227.42	-84.76	-834.21	-1,225.2
Price/Cash Flow High	- -	- -	- -	- -	-8.16	-9.85	-14.07	-12.72	-7.78	-14.86	-29.86	424.35	-719.6	-1,342.27	-2,485.46
Price/Cash Flow Low	- -	- -	- -	- -	-0.06	-4.45	-8.22	-3.48	-2.46	-4.41	-11.68	164.11	-5.77	-423.47	-444.26
Price/Free Cash Flow Average	- -	- -	- -	- -	-7.19	-7.44	-11.51	-10.37	-4.84	-8	-17.53	163.61	-86.81	-855.14	-1,259.97
Price/Free Cash Flow High	- -	- -	- -	- -	-9.27	-10.71	-14.7	-14.23	-7.89	-14.9	-30.29	305.29	-736.99	-1,375.94	-2,555.98
Price/Free Cash Flow Low	- -	- -	- -	- -	-0.07	-4.85	-8.59	-3.9	-2.49	-4.42	-11.86	118.07	-5.91	-434.09	-456.87
EV/Sales Average	- -	6.12	7.68	0.41	116.51	126.03	168.75	185.87	99.11	165.26	90.55	15.78	266.89	2,023.27	1,589.73
EV/Sales High	- -	6.12	7.68	0.41	148.74	182.62	220.73	261.2	164.07	341.05	166.63	29.96	2,294.27	3,258.35	3,227.73
EV/Sales Low	- -	6.12	7.68	0.41	6.38	81.25	121.11	59.77	49.09	74.02	56.73	11.22	14.64	1,024.75	574.7
EV/EBITDA Average	0.58	-0.47	-0.64	-0.02	-4.96	-5.24	-8.09	-6.98	-4.08	-5.23	-7.3	-10.64	-99.3	-920.94	-1,097.73
EV/EBITDA High	0.58	-0.47	-0.64	-0.02	-6.34	-7.59	-10.59	-9.8	-6.76	-10.8	-13.43	-20.21	-853.63	-1,483.11	-2,228.79
EV/EBITDA Low	0.58	-0.47	-0.64	-0.02	-0.27	-3.38	-5.81	-2.24	-2.02	-2.34	-4.57	-7.57	-5.45	-466.44	-396.84
EV/EBIT Average	0.5	-0.41	-0.57	-0.02	-4.49	-4.81	-7.44	-6.42	-3.77	-4.83	-7.17	-10.3	-96.52	-894.82	-1,062.49
EV/EBIT High	0.5	-0.41	-0.57	-0.02	-5.73	-6.97	-9.73	-9.02	-6.24	-9.97	-13.19	-19.56	-829.75	-1,441.06	-2,157.25
EV/EBIT Low	0.5	-0.41	-0.57	-0.02	-0.25	-3.1	-5.34	-2.06	-1.87	-2.16	-4.49	-7.32	-5.3	-453.21	-384.1
Last Price	- -	- -	- -	- -	4.32	3.76	2.25	1	0.82	1.74	2.49	1.11	107.69	49.26	160.68
High Price	- -	- -	- -	- -	4.56	4.28	3.75	3.1	1.71	1.96	4.28	2.65	119.05	154.83	204.34
Enterprise Value Average	-9	10	22	1	295	284	302	263	146	128	353	232	2,387	19,219	23,140
Enterprise Value High	-9	10	22	1	377	411	396	370	242	264	649	441	20,522	30,951	46,983
Enterprise Value Low	-9	10	22	1	16	183	217	85	73	57	221	165	131	9,734	8,365

Shares Outstanding	49	49	57	78	90	103	127	127	150	153	169	170	175	220	243
Diluted Weighted Avg Shares	47	49	54	66	80	100	114	127	146	150	165	170	173	200	230
Basic Weighted Avg Shares	47	49	54	66	80	97	114	127	146	150	165	170	173	200	230
Revenue per Share	0.04	0.03	0.05	0.03	0.03	0.02	0.02	0.01	0.01	0.01	0.02	0.09	0.05	0.05	0.06
EBITDA per Share	-0.35	-0.45	-0.64	-0.64	-0.75	-0.56	-0.33	-0.3	-0.25	-0.16	-0.29	-0.13	-0.14	-0.1	-0.09
Operating Income per Share	-0.4	-0.51	-0.71	-0.76	-0.83	-0.61	-0.36	-0.32	-0.27	-0.18	-0.3	-0.13	-0.14	-0.11	-0.09
Basic EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Basic EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Diluted EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Diluted EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.29	-0.4	-0.54	-0.58	-0.56	-0.43	-0.27	-0.24	-0.22	-0.13	-0.14	0.01	-0.17	-0.12	-0.08
Free Cash Flow per Basic Share	-0.31	-0.41	-0.59	-0.6	-0.63	-0.46	-0.28	-0.27	-0.22	-0.13	-0.15	- -	-0.17	-0.12	-0.08
Cash & Equivalents per Share	0.47	0.09	0.1	0.44	0.54	0.23	0.33	0.24	0.21	0.28	0.35	0.34	0.21	0.24	0.24
Book Value per Share	0.74	0.36	1.06	0.79	0.55	1.25	1.42	0.73	0.78	0.67	0.59	0.45	0.39	0.41	0.21
Tangible Book Value per Share	0.49	0.08	-0.07	0.31	0.54	1.24	1.37	0.7	0.36	0.25	0.2	0.09	0.03	0.1	- -

Lineage Cell Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)